Omega Flex, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Omega Flex, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	94.1	102	108	111	106	130	125	111	102	98.3
Cost of revenue	36.2	40	42.2	40.9	39.2	48.5	47.2	43.1	39.4	39.3
Gross profit	57.9	61.8	66.1	70.5	66.6	81.5	78.3	68.4	62.3	59
Research and development	0.79	0.92	1.53	1.19	0.83	0.63	0.65	0.43	0.3	1.28
General and administrative	17.1	17.9	17.8	24.8	19.1	21.4	20.6	17.7	16.1	16.3
Operating income	21.9	24.2	26.4	21.9	26.7	35.1	31	25.8	21.6	16.9
Other non-operating income	-0.47	-0.04	-0.13	0.06	-0.05	0.02	-0.21	0.05	-0.23	0.33
Pre-tax income	21.5	24.3	26.7	22.9	26.6	35.1	31	27.5	23.6	19.3
Income tax	6.98	8.45	6.45	5.43	6.59	8.86	7.33	6.83	5.71	4.67
Net income to minority interests		0.18	0.14	0.14	0.06	0.06	0.03	-0.04	-0.1	-0.24
Net income	14.4	15.7	20.1	17.3	19.9	26.2	23.6	20.8	18	14.8
EBITDA	22.4	24.7	26.9	22.6	27.5	36.1	32.1	26.9	22.8	18.3
EPS, basic	1.42	1.55	2.00	1.71	1.97	2.60	2.34	2.06	1.78	1.47
EPS, diluted	1.42	1.55	2.00	1.71	1.97	2.60	2.34	2.06	1.78	1.47
Shares, basic (weighted)	10.1	0.01	10.1	0.01	10.1	10.1	10.1	10.1	10.1	10.1
Shares, diluted (weighted)	10.1	0.01	10.1	0.01	0.01	10.1	10.1	10.1	10.1	10.1
Dividend per share	0.85	0.66	0.94	4.58	1.12	1.18	1.26	1.31	1.35	1.36

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	35.3	37.9	32.4	16.1	23.6	32.9	37.7	46.4	51.7	53.2
Short-term investments			14.9
Receivables			16.5	17	20.1	20.7	17.5	15.4	14.4	13.7
Inventory	7.37	8.01	7.98	11.1	11.5	15.6	17.8	15.6	14.6	13.4
Other current assets	1.98	1.9	1.86	2.1	2.14	2.53	2.79	2.87	2.98	2.73
Total current assets	59.7	63.5	73.6	46.3	57.4	71.7	75.8	80.2	83.6	83
Property, plant and equipment	4.4	7	8.38	8.91	8.6	8.57	8.4	8.95	9.7	10.2
Lease right-of-use assets				0.77	0.49	3.37	3.21	2.94	4.94	4.44
Goodwill	3.53	3.53	3.53	3.53	3.53	3.53	3.53	3.53	3.53	3.53
Other non-current assets	2.94	3.08	1.31	1.45	1.59	1.7	5.87	4.44	3.73	3.22
Total assets	70.6	77.1	86.8	61	71.6	88.9	97.7	100	106	105
Accounts payable	2.31	2.6	2.78	2.38	2.47	3.36	2.29	2.09	2.66	2.53
Total current liabilities	22.7	18.1	18.4	20.5	21.9	22.8	22.4	18.1	17.4	16
Lease liabilities				0.42	0.25	2.99	2.76	2.49	4.57	3.99
Other non-current liabilities	1.62	1.95	1.54	2.18	2.39	1.67	0.99	0.6	0.53	0.58
Total liabilities	24.5	21	20.5	23.4	25.2	28.4	26.5	21.4	22.7	20.9
Paid-in capital	10.8	10.8	10.8	11	11	11	11	11	11	11
Retained earnings	36.5	45.5	56.1	27.2	35.8	50.1	61	68.5	72.9	74
Treasury stock	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Other comprehensive income	-1.69	-0.91	-0.95	-0.91	-0.78	-0.83	-1.1	-0.93	-0.89	-0.93
Shareholders' equity	45.7	55.5	66.1	37.4	46.1	60.4	71	78.7	83.1	84.2
Minority interests	0.38	0.61	0.25	0.19	0.26	0.19	0.2	0.16	0.07	-0.18
Total equity	46.1	56.1	66.3	37.6	46.4	60.5	71.2	78.9	83.2	84
Total liabilities and equity	70.6	77.1	86.8	61	71.6	88.9	97.7	100	106	105
Shares outstanding	10.1	10.1	10.1	10.1	10.1	10.1	10.1	10.1	10.1	10.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	14.5	15.8	20.3	17.4	20	26.3	23.7	20.7	17.9	14.6
Depreciation and amortization	0.46	0.5	0.54	0.72	0.87	1.02	1.1	1.1	1.26	1.36
Stock-based compensation	1	1.04	0.12	2.47	1.45	0.51	0.16	0.29	0.05	0.17
Deferred income tax	-0.14	0.07	0.37	-0.24	-0.21	0.31	-1.34	0.73	0.01	0.05
Change in receivables	1.22	-0.46	-0.98	-1.28	-2.68	-0.94	3.4	2.18	1.23	0.77
Change in inventory	0.59	-0.7	0.06	-3.03	-0.44	-4.19	-2.58	1.23	0.83	1.37
Change in payables	-0.11	0.25	0.21	-0.4	0.08	0.89	-1	-0.21	0.57	-0.14
Cash from operations	14.8	18	21.1	16	19.3	25.1	15.2	23.4	20.9	17.2
Capital expenditures	-0.23	-3.09	-1.92	-1.23	-0.56	-0.97	-0.94	-1.64	-2.01	-1.82
Purchases of investments			-35.1	-55.9
Cash from investing	-0.23	-3.09	-16.9	13.7	-0.56	-0.97	-0.94	-1.64	-2.01	-1.82
Dividends paid	-8.58	-13	-9.78	-46	-11.3	-14.9	-9.49	-13.1	-13.5	-13.7
Cash from financing	-8.58	-13	-9.78	-46	-11.3	-14.9	-9.49	-13.1	-13.5	-13.7
Exchange rate effect	-0.78	0.68	0.04
Net change in cash	5.95	1.94	-5.59	-16.3	7.44	9.31	4.82	8.66	5.32	1.62
Free cash flow	14.5	15	19.1	14.8	18.7	24.2	14.3	21.8	18.9	15.4
Interest paid					0.11
Income taxes paid	7.06	7.61	7.31	5.43	6.44	9.6	8.68	6.06	5.54	5.83

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $25.54 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	57.8%	Gross profit / revenue.
Operating margin	14.0%	Operating income / revenue.
EBITDA margin	15.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	15.9%	Pre-tax income / revenue.
Net margin	12.3%	Net income / revenue.
FCF margin	11.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.0%	Cash from operations / revenue.
Effective tax rate	24.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.8%	Net income / average total assets.
Return on invested capital (ROIC)	29.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.8%	Capital expenditures / revenue.
D&A / revenue	1.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-7.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-9.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-21.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-18.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-8.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-19.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-17.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-7.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-17.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-14.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-5.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-17.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-14.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-5.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-17.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-2.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-18.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	2.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-3.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	2.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	12.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	298.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	5.63x	Current assets / current liabilities.
Quick ratio	4.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	3.42x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	18.8%	Total liabilities / total assets.
Working capital	$64.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	3.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$78.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.96x	Revenue / average total assets.
Fixed asset turnover	9.32x	Revenue / average property, plant and equipment.
Inventory turnover	2.77x	Cost of revenue / average inventory.
Days inventory	132 days	365 x average inventory / cost of revenue.
Receivables turnover	6.69x	Revenue / average receivables.
Days sales outstanding	55 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	160 days	Days inventory + days sales outstanding - days payables.
FCF conversion	91.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	13.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1,174.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$9,569.00	Revenue / diluted weighted shares.
FCF per share	$1,073.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1,242.00	Cash from operations / diluted weighted shares.
Book value per share	$8.13	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.78	Tangible book value / shares outstanding.
Cash per share	$4.75	(Cash + short-term investments) / shares outstanding.
Payout ratio	115.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	126.8%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$257.8M	Share price x shares outstanding.
Enterprise value	$209.9M	Market cap + total debt - cash - short-term investments.
P/E	21.7x	Market cap / net income. Only when net income is positive.
P/S	2.67x	Market cap / revenue.
P/B	3.14x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.28x	Market cap / tangible book value, when positive.
P/FCF	23.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	20.6x	Market cap / cash from operations, when positive.
EV/Sales	2.17x	Enterprise value / revenue.
EV/EBIT	15.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.2%	Free cash flow / market cap.
Earnings yield	4.6%	Net income / market cap (the inverse of P/E).
Dividend yield	5.3%	Dividends paid over the period / market cap.
Shareholder yield	5.3%	(Dividends paid + share buybacks) / market cap.

What was Omega Flex, Inc.'s revenue in fiscal 2025?

Omega Flex, Inc. reported revenue of $98.3M for fiscal 2025, 3.3% lower than the year before.

Was Omega Flex, Inc. profitable in fiscal 2025?

Yes. Net income was $14.8M, a net margin of 15.1%.

How much free cash flow did Omega Flex, Inc. generate in fiscal 2025?

Cash from operations of $17.2M minus capital expenditures of $1.8M left free cash flow of $15.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Omega Flex, Inc.